Aleksander Martek, B; Mihelač, M; Gazvoda, M; Virant, M; Urankar, D; Krivec, M; Gostič, T; Nemec, B; Koštrun, B; Janežič, M; Klemenc, S; Košmrlj, J. 1H−15N HMBC NMR as a tool for rapid identification of isomeric azaindoles: The case of 5F-MDMB-P7AICA. Drug Test. Anal., 7 Feb 2019, 11 (4), 617-625. 1.5 MB. https://doi.org/10.1002/dta.2573 #CUMYL‐4CN‐B7AICA GC,MS,NMR,IR,UV,other
EMCDDA. New drugs in Europe, 2017, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Aug 2017. 672 kB. #27
Banister, SD; Connor, M. The chemistry and pharmacology of synthetic cannabinoid receptor agonist new psychoactive substances: Evolution. In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 191-226. 1.2 MB. https://doi.org/10.1007/164_2018_144 #98
Anon. Ordinance amending the Annex to the New Psychoactive Substances Act [Neue-psychoaktive-Stoffe-Gesetz] as well as Annexes to the Narcotics Act [Betäubungsmittelgesetz]. 14 Mar 2019. 704 kB. #CUMYL-4CN-B7AICA
Alam, RM; Keating, JJ. Adding more “spice” to the pot: A review of the chemistry and pharmacology of newly emerging heterocyclic synthetic cannabinoid receptor agonists. Drug Test. Anal., 1 Mar 2020, 12 (3), 297–315. 2.8 MB. https://doi.org/10.1002/dta.2752 #26 Structure 71 has a single bond where a double bond belongs